PHILADELPHIA — Tavapadon, an experimental first-in-class oral selective partial D1/D5 dopamine receptor agonist for Parkinson's disease (PD), was shown to significantly reduce disease burden in two ...
The ergot derivative, bromocriptine mesylate (Cycloset) is approved by the Food and Drug Administration (FDA) as an adjunct to diet and exercise to improve glycemic control in adults with type 2 ...
A new study found that people with depression and anxiety who used GLP-1 drugs like Ozempic and Wegovy had a 42% lower risk ...
"We found that D1 receptor antagonists—drugs that block D1 receptors from activation—decreased the dopamine-mediated inhibition of insulin secretion. We also saw that overexpression of only D2 ...
Morning Overview on MSN
Study: Acetylcholine timing shapes dopamine’s role in brain circuits
A growing body of mouse and rat research is rewriting the textbook on how dopamine, the brain’s primary reward signal, ...
SPOKANE, Wash. — One of the pressing questions that was asked during the pandemic was what the long-term effects of COVID-19 were on the body, if anything? A new study is beginning to answer that ...
Mount Sinai researchers have discovered distinct roles for two dopamine receptors located on nerve cells within the portion of the brain that controls approach vs. avoidance behavior. These receptors ...
Dopamine has a dark side. Substances that give us great pleasure, from coffee to cocaine, can raise dopamine levels too high.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results